CONTENTS:
• Health-care reform provides an opportunity for evidence-based alcohol treatment in the USA: the National Institute for Health and Clinical Excellence (NICE) guideline as a model [Editorial]. McCrady B.S., p. 231-232.
• Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research [For debate]. Jones H.E., Chisolm M.S., Jansson L.M., Terplan M., p. 233-247.
• An ethical framework for conducting research on pregnant, opioid-dependent women. McCullough L.B., Chervenak F.A., Coverdale J.H., p. 248-249.
• Dual dilemma - should naltrexone be used in the treatment of opioid-dependent pregnant women? Stitzer M.L., p. 249-250.
• Blocking endogenous opioids during development - do we understand the consequences? White J., p. 251-252.
• Is sustained release natrexone an option for heroin-dependent pregnant women? Waal H., p. 252-253.
• Double trouble - pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research. Clark N., Verster A., p. 253-255.
• Naltrexone in the treatment of opioid-dependent pregnant women: common ground. Jones H.E., Chisolm M.S., Jansson L.M., Terplan M., p. 255-256.
• Conversation with Christine Godfrey. 257-264.
• Swedish alcohol consumption on the threshold of modernity: legislation, attitudes and national economy c. 1775-1855. Enefalk H., p. 265-274.
• Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Maisel N.C., Blodgett J.C., Wilbourne P.L., Humphreys K., Finney J.W., p. 275-293.
• Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Hitsman B., Papandonatos G.D., McChargue D.E., DeMott A., Herrera M.J., Spring B., et al., p. 294-306.
• Smoking and absence from work: systematic review and meta-analysis of occupational studies. Weng S.F., Ali S., Leonardi-Bee J., p. 307-319.
• Living in proximity of a bar and risky alcohol behaviours: a longitudinal study. Halonen J.I., Kivimäki M., Virtanen M., Pentti J., Subramanian S.V., Kawachi I., et al., p. 320-328.
• Commentary on Halonen et al. (2013): Exposure to alcohol outlets and alcohol consumption - back to square one? Scribner R., p. 329-330.
• Web-based alcohol intervention for Māori university students: double-blind, multi-site randomized controlled trial. Kypri K., McCambridge J., Vater T., Bowe S.J., Saunders J.B., Cunningham J.A., et al., p. 331-338.
• Differences in liquor prices between control state-operated and license-state retail outlets in the United States. Siegel M., DeJong W., Albers A.B., Naimi T.S., Jernigan D.H., p. 339-347.
• Missed and inconsistent classification of current drinkers: results from the 2005 US National Alcohol Survey. Midanik L.T., Ye Y., Greenfield T.K., Kerr W., p. 348-355.
• An intervention targeting service providers and clients for methadone maintenance treatment in China: a cluster-randomized trial. Li L., Wu Z., Liang L.-J., Lin C., Zhang L., Guo S., et al., p. 356-366.
• Prescription drug use among pregnant women in opioid Maintenance Treatment. Lund I.O., Skurtveit S., Engeland A., Furu K., Ravndal E., Handal M., p. 367-376.
• A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006. Merrall E.L.C., Bird S.M., Hutchinson S.J., p. 377-384.
• Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme. Butland B.K., Field-Smith M.E., Ramsey J.D., Anderson H.R., p. 385-393.
• Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Ward K.D., Asfar T., Al Ali R., Rastam S., Weg M.W.V., Eissenberg T., et al., p. 394-403.
• Commentary on Ward et al. (2013): Failure to find a treatment effect for NRT in a low-income country - implications. Lando H., p. 404-405.
• Nicotine metabolism and addiction among adolescent smokers. Rubinstein M.L., Shiffman S., Moscicki A.-B., Rait M.A., Sen S., Benowitz N.L., p. 406-412.
• Visual attention to health warnings on plain tobacco packaging in adolescent smokers and non-smokers. Maynard O.M., Munafò M.R., Leonards U., p. 413-419.
• Exposure to second-hand smoke damages everyday prospective memory. Heffernan T.M., O'Neill T.S., p. 420-426.
• What is best evidence in epidemiology? A Reply to Stockwell (2012). Roerecke M., Rehm J., p. 427-428.
• A reply to Roerecke & Rehm: Continuing questions about alcohol and health benefits. Stockwell T., p. 428-429.
• On the evidence of a cardioprotective effect of alcohol consumption. Roerecke M., Rehm J., p. 429-431.
• An alcohol and other drugs library: building capacity and adding value. Dunne M., p. 431-432.
• The important role of libraries and librarians in addictions. Lemmens P., p. 432.
• Loss of materials and resources for addiction researchers: comment on Mitchell et al. (2012). Corkery J.M., p. 432-433.
• Remembering 'Collective amnesia: reversing the global epidemic of addiction library closures'. Campbell N.D., p. 434.
• Mitchell et al. editorial on library closures. Berridge V., Mold A., p. 434-435.
• Further reflections on the loss of addiction libraries and databases. White W.L., p. 435-436.
• Addiction libraries in Australia: collective amnesia threat. Templeman D., Shelling J., p. 436.
• Letter in response to Mitchell et al. 'Collective amnesia: reversing the global epidemic of addiction library closures'. Silver I.L., p. 437.
• The tragedy of lost libraries. Reinarman C., p. 437-438.
• Comment on the Mitchell et al. editorial. Tremper M., p. 438.
• Further reflections. Mitchell A.L., Lacroix S., Weiner B.S., Imholtz C., Goodair C., p. 438-439.